Regulatory T-cell Subpopulations in Severe or Early-onset Preeclampsia

American Journal of Reproductive Immunology

Volumn 74, Issue 4, 2015, Pages 368-378

  Boij, Roland ^a,b   Mjösberg, Jenny ^c   Svensson Arvelund, Judit ^a   Hjorth, Maria ^a   Berg, Göran ^a   Matthiesen, Leif ^a,d   Jenmalm, Maria C ^a   Ernerudh, Jan ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b RYHOV COUNTY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Early onset preeclampsia; Preeclampsia; Pregnancy; Regulatory T cells

Indexed keywords

BETAMETHASONE; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CCR4 PROTEIN, HUMAN; CORTICOSTEROID; CTLA4 PROTEIN, HUMAN;

ADULT; ARTICLE; CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FEMALE; FLOW CYTOMETRY; HUMAN; MATERNAL HYPERTENSION; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEINURIA; REGULATORY T LYMPHOCYTE; RISK ASSESSMENT; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY; METABOLISM; PREGNANCY; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CD4 LYMPHOCYTE COUNT; CTLA-4 ANTIGEN; FEMALE; FLOW CYTOMETRY; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CCR4; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84941743880     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12410     Document Type: Article

References (56)

1. Duley L: The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009; 33:130-137.
2. Redman CW, Sargent IL: Immunology of pre-eclampsia. Am J Reprod Immunol 2010; 63:534-543.
3. Matthiesen L, Berg G, Ernerudh J, Ekerfelt C, Jonsson Y, Sharma S: Immunology of preeclampsia. Chem Immunol Allergy 2005; 89:49-61.
4. Laresgoiti-Servitje E: A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol 2013; 94:247-257.
5. Catarino C, Santos-Silva A, Belo L, Rocha-Pereira P, Rocha S, Patricio B, Quintalinha A, Rebelo I: Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. J Pregnancy 2012; 2012:684384.
6. Boij R, Svensson J, Nilsson-Ekdahl K, Sandholm K, Lindahl TL, Palonek E, Garle M, Berg G, Ernerudh J, Jenmalm M, Matthiesen L: Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia. Am J Reprod Immunol 2012; 68:258-270.
7. Jonsson Y, Ruber M, Matthiesen L, Berg G, Nieminen K, Sharma S, Ernerudh J, Ekerfelt C: Cytokine mapping of sera from women with preeclampsia and normal pregnancies. J Reprod Immunol 2006; 70:83-91.
8. Darmochwal-Kolarz D, Leszczynska-Gorzelak B, Rolinski J, Oleszczuk J: T helper 1- and T helper 2-type cytokine imbalance in pregnant women with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1999; 86:165-170.
9. Matthiesen L, Berg G, Ernerudh J, Skogh T: Lymphocyte subsets and autoantibodies in pregnancies complicated by placental disorders. Am J Reprod Immunol 1995; 33:31-39.
10. Chaiworapongsa T, Gervasi MT, Refuerzo J, Espinoza J, Yoshimatsu J, Berman S, Romero R: Maternal lymphocyte subpopulations (CD45RA+ and CD45RO+) in preeclampsia. Am J Obstet Gynecol 2002; 187:889-893.
11. Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T: Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117:550-555.
12. Szarka A, Rigo J Jr, Lazar L, Beko G, Molvarec A: Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 2010; 11:59.
13. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T: Regulatory T cells: how do they suppress immune responses? Int Immunol 2009; 21:1105-1111.
14. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 1:1245-1253.
15. Saito S, Sasaki Y, Sakai M: CD4(+)CD25 high regulatory T cells in human pregnancy. J Reprod Immunol 2005; 65:111-120.
16. Vignali DA, Collison LW, Workman CJ: How regulatory T cells work. Nat Rev Immunol 2008; 8:523-532.
17. Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT: Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology 2004; 112:38-43.
18. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S: Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol Hum Reprod 2004; 10:347-353.
19. Toldi G, Saito S, Shima T, Halmos A, Veresh Z, Vasarhelyi B, Rigo J Jr, Molvarec A: The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol 2012; 68:175-180.
20. Heikkinen J, Mottonen M, Alanen A, Lassila O: Phenotypic characterization of regulatory T cells in the human decidua. Clin Exp Immunol 2004; 136:373-378.
21. Kisielewicz A, Schaier M, Schmitt E, Hug F, Haensch GM, Meuer S, Zeier M, Sohn C, Steinborn A: A distinct subset of HLA-DR+-regulatory T cells is involved in the induction of preterm labor during pregnancy and in the induction of organ rejection after transplantation. Clin Immunol 2010; 137:209-220.
22. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH, Scherjon SA: Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27(Suppl A):S47-S53.
23. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, Claas FH: Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol 2008; 15:5737-5745.
24. Steinborn A, Haensch GM, Mahnke K, Schmitt E, Toermer A, Meuer S, Sohn C: Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 2008; 129:401-412.
25. Wegienka G, Havstad S, Bobbitt KR, Woodcroft KJ, Zoratti EM, Ownby DR, Cole Johnson C: Within-woman change in regulatory T cells from pregnancy to the postpartum period. J Reprod Immunol 2010; 88:58-65.
26. Ernerudh J, Berg G, Mjosberg J: Regulatory T helper cells in pregnancy and their roles in systemic versus local immune tolerance. Am J Reprod Immunol 2011; 66(Suppl 1):31-43.
27. Dimova T, Nagaeva O, Stenqvist AC, Hedlund M, Kjellberg L, Strand M, Dehlin E, Mincheva-Nilsson L: Maternal Foxp3 expressing CD4+ CD25+ and CD4+ CD25- regulatory T-cell populations are enriched in human early normal pregnancy decidua: a phenotypic study of paired decidual and peripheral blood samples. Am J Reprod Immunol 2011; 66(Suppl 1):44-56.
28. Mjosberg J, Berg G, Jenmalm MC, Ernerudh J: FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol Reprod 2010; 82:698-705.
29. Tsuda H, Michimata T, Hayakawa S, Tanebe K, Sakai M, Fujimura M, Matsuchima K, Saito S: A Th2 chemokine, TARC, produced by trophoblasts and endometrial gland cells, regulates the infiltration of CCR4+ T lymphocytes into human decidua at early pregnancy. Am J Reprod Immunol 2002; 48:1-8.
30. Jiang TT, Chaturvedi V, Ertelt JM, Kinder JM, Clark DR, Valent AM, Xin L, Way SS: Regulatory T cells: new keys for further unlocking the enigma of fetal tolerance and pregnancy complications. J Immunol 2014; 1:4949-4956.
31. Steinborn A, Schmitt E, Kisielewicz A, Rechenberg S, Seissler N, Mahnke K, Schaier M, Zeier M, Sohn C: Pregnancy-associated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol 2012; 167:84-98.
32. Hu D, Chen Y, Zhang W, Wang H, Wang Z, Dong M: Alteration of peripheral CD4+CD25+ regulatory T lymphocytes in pregnancy and pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87:190-194.
33. Paeschke S, Chen F, Horn N, Fotopoulou C, Zambon-Bertoja A, Sollwedel A, Zenclussen MN, Casalis PA, Dudenhausen JW, Volk HD, Zenclussen AC: Pre-eclampsia is not associated with changes in the levels of regulatory T cells in peripheral blood. Am J Reprod Immunol 2005; 54:384-389.
34. Ilekis JV, Reddy UM, Roberts JM: Preeclampsia-a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop. Reprod Sci 2007; 14:508-523.
35. Dimeloe S, Nanzer A, Ryanna K, Hawrylowicz C: Regulatory T cells, inflammation and the allergic response-The role of glucocorticoids and Vitamin D. J Steroid Biochem Mol Biol 2010; 31:86-95.
36. Mjosberg J, Svensson J, Johansson E, Hellstrom L, Casas R, Jenmalm MC, Boij R, Matthiesen L, Jönsson JI, Berg G, Ernerudh J: Systemic reduction of functionally suppressive CD4dimCD25highFoxp3+ Tregs in human second trimester pregnancy is induced by progesterone and 17beta-estradiol. J Immunol 2009; 1:759-769.
37. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA, Kapranov P, Gingeras TR, de Fazekas St Groth B, Clayberger C, Soper DM, Ziegler SF, Bluestone JA: CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 10:1701-1711.
38. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S: Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 19:899-911.
39. American College of Obstetricians and gynecologists ibI. Hypertension, Pregnancy-Induced-Practice Guideline. 2013.
40. Raymond D, Peterson E: A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 66:497-506.
41. Witlin AG, Saade GR, Mattar F, Sibai BM: Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation. Am J Obstet Gynecol 2000; 182:607-611.
42. Miyara M, Gorochov G, Ehrenstein M, Musset L, Sakaguchi S, Amoura Z: Human FoxP3+ regulatory T cells in systemic autoimmune diseases. Autoimmun Rev 2011; 10:744-755.
43. Darmochwal-Kolarz D, Kludka-Sternik M, Tabarkiewicz J, Kolarz B, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J: The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsia. J Reprod Immunol 2012; 93:75-81.
44. Prins JR, Boelens HM, Heimweg J, Van der Heide S, Dubois AE, Van Oosterhout AJ, Erwich JJ: Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens Pregnancy 2009; 28:300-311.
45. Toldi G, Svec P, Vasarhelyi B, Meszaros G, Rigo J, Tulassay T, Treszl A: Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand 2008; 87:1229-1233.
46. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, Shiozaki A, Rolinski J, Saito S: Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol 2007; 149:139-145.
47. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, de St F, Groth B, Nanan R: Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 1:7023-7030.
48. Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, Nanan Rl: Altered decidual DC-SIGN+ antigen-presenting cells and impaired regulatory T-cell induction in preeclampsia. Am J Pathol 2012; 181:2149-2160.
49. Vatten LJ, Skjaerven R: Is pre-eclampsia more than one disease? BJOG 2004; 111:298-302.
50. Karagiannidis C, Akdis M, Holopainen P, Woolley NJ, Hense G, Ruckert B, Mantel PY, Menz G, Akdis CA, Blaser K, Schmidt-Weber CB: Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 2004; 114:1425-1433.
51. Navarro J, Aristimuno C, Sanchez-Ramon S, Vigil D, Martinez-Gines ML, Fernandez-Cruz E, de Andrés C: Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J Neuroimmunol 2006; 176:153-161.
52. Chen X, Oppenheim JJ, Winkler-Pickett RT, Ortaldo JR, Howard OM: Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3(+)CD4(+)CD25(+) T regulatory cells in vivo and enhances their capacity to suppress EAE. Eur J Immunol 2006; 36:2139-2149.
53. Moraes-Fontes MF, Rebelo M, Caramalho I, Zelenay S, Bergman ML, Coutinho A, Zelenay S, Bergman ML, Coutinho A, Demengeot J: Steroid treatments in mice do not alter the number and function of regulatory T cells, but amplify cyclophosphamide-induced autoimmune disease. J Autoimmun 2009; 33:109-120.
54. Wing K, Yamaguchi T, Sakaguchi S: Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation. Trends Immunol 2011; 32:428-433.
55. Lim HW, Broxmeyer HE, Kim CH: Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol 2006; 15:840-851.
56. Quinn KH, Lacoursiere DY, Cui L, Bui J, Parast MM: The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol 2011; 91:76-82.